Previous 10 | Next 10 |
Phio Pharmaceuticals to Participate in the H.C. Wainwright BioConnect 2021 Conference PR Newswire MARLBOROUGH, Mass. , Jan. 4, 2021 /PRNewswire/ -- Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a biotechnology company developing the next generation of immuno-on...
Universal Security Instruments (UUU) +293%.Technical Communications (TCCO) +214%.Koss Corporation (KOSS) +99%.Tenax Therapeutics (TENX) +80%.New Concept Energy (GBR) +58%.IRIDEX Corporation (IRIX) +23%.SOS Limited (SOS) +10% after announcing partnership with Zhonglu P&C Insuranc...
Nabriva Therapeutics NBRV -30% after priced $15M public offering.Aytu BioScience (AYTU) -25% on raising 'bought deal' offering to $25M.Immutep (IMMP) -24%.Professional Diversity Network (IPDN) -24%.SELLAS Life Sciences Group SLS -21% after announcing positiv...
Penny Stocks to Watch Today Finding the best penny stocks to buy seems simple, but it takes time to identify a clear trend. We saw this week, how quickly these can breakout. We’ve also seen how quickly they can break down. So deciding what type of trading strategy you’...
Phio Pharmaceuticals to Participate in the 3rd Annual Evercore ISI HealthCONx Conference PR Newswire MARLBOROUGH, Mass., Nov. 19, 2020 MARLBOROUGH, Mass. , Nov. 19, 2020 /PRNewswire/ -- Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a biotechnology company d...
Phio Pharmaceuticals (PHIO): Q3 GAAP EPS of -$0.40 misses by $0.02.Cash in hand of ~$16.9M.Shares -2.35% AH.Press Release For further details see: Phio Pharmaceuticals EPS misses by $0.02
Phio Pharmaceuticals Reports Third Quarter 2020 Financial Results and Provides Business Update PR Newswire MARLBOROUGH, Mass., Nov. 10, 2020 MARLBOROUGH, Mass. , Nov. 10, 2020 /PRNewswire/ -- Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a biotechnology company ...
Beyond Meat (BYND) -23% on Q3 earnings release.InnSuites Hospitality (IHT) -20%.Jumia Technologies (JMIA) -19% on Q3 earnings release.Aurora Cannabis (ACB) -13%.Applied UV (AUVI) -13%.GasLog Partners (GLOP) -13% on Q3 earnings release.Waitr Holdings (WTRH) -...
Phio Pharmaceuticals (PHIO) jumps 22% premarket after in reaction to positive data from an in vivo study that shows the strong antitumoral efficacy of individual INTASYL pipeline products, including PH-762, PH-790 and PH-804.These data were presented during The Society for Immu...
Phio Announces Positive In Vivo Data On Combination PD-1 And TIGIT Checkpoint Blockade With INTASYL In A Single Therapeutic For Cancer Treatment The new data was presented at the SITC 2020 Virtual Scientific Program PR Newswire MARLBOROUGH, Mass., Nov. 9, 2020 ...
News, Short Squeeze, Breakout and More Instantly...
Phio Pharmaceuticals Corp. Company Name:
PHIO Stock Symbol:
NASDAQ Market:
Phio Pharmaceuticals Corp. Website:
Marlborough, Massachusetts--(Newsfile Corp. - July 12, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) (the "Company"), a clinical stage biotechnology company whose proprietary INTASYL® siRNA gene silencing technology is designed to make immune cells more effective in killing tumor cells...
Five sites across the U.S. are now participating in the Phase 1b study Marlborough, Massachusetts--(Newsfile Corp. - July 8, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical stage biotechnology company whose proprietary INTASYL® siRNA gene silencing technology is designed to ...
Marlborough, Massachusetts--(Newsfile Corp. - July 5, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical stage biotechnology company whose proprietary INTASYL® siRNA gene silencing technology is designed to make immune cells more effective in killing tumor cells, today announced i...